N
BLUE

Nuveen’s bluebird bio BLUE Stock Holding History

Nuveen’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,721
Closed -$106K – 3288
2024
Q4 		$106K Sell
12,721
-7,772
-38% -$67.9K ﹤0.01% 3285
2024
Q3 		$213K Hold
20,493
– – ﹤0.01% 3211
2024
Q2 		$403K Hold
20,493
– – ﹤0.01% 3060
2024
Q1 		$525K Buy
20,493
+5,029
+33% +$129K ﹤0.01% 2960
2023
Q4 		$427K Buy
15,464
+199
+1% +$12.1K ﹤0.01% 3056
2023
Q3 		$928K Sell
15,265
-123
-0.8% -$8.64K ﹤0.01% 2607
2023
Q2 		$1.01M Buy
15,388
+678
+5% +$49.6K ﹤0.01% 2656
2023
Q1 		$936K Sell
14,710
-39,508
-73% -$4.51M ﹤0.01% 2636
2022
Q4 		$7.5M Sell
54,218
-1,784
-3% -$251K ﹤0.01% 1679
2022
Q3 		$7.09M Buy
56,002
+39,750
+245% +$4.5M ﹤0.01% 1692
2022
Q2 		$1.34M Sell
16,252
-7,112
-30% -$552K ﹤0.01% 2648
2022
Q1 		$2.25M Buy
23,364
+765
+3% +$101K ﹤0.01% 2450
2021
Q4 		$4.51M Sell
22,599
-20,246
-47% -$4.78M ﹤0.01% 2178
2021
Q3 		$10.6M Sell
42,845
-10,460
-20% -$2.99M ﹤0.01% 1737
2021
Q2 		$22.1M Buy
53,305
+16,386
+44% +$6.49M 0.01% 1289
2021
Q1 		$14.4M Sell
36,919
-8,469
-19% -$4.17M ﹤0.01% 1561
2020
Q4 		$25.4M Sell
45,388
-2,576
-5% -$1.63M 0.01% 1092
2020
Q3 		$33.5M Sell
47,964
-8,150
-15% -$6.36M 0.01% 755
2020
Q2 		$44.4M Buy
56,114
+16,067
+40% +$12.1M 0.02% 591
2020
Q1 		$23.8M Buy
40,047
+1,417
+4% +$1.38M 0.01% 808
2019
Q4 		$43.9M Buy
38,630
+6,888
+22% +$7.49M 0.02% 738
2019
Q3 		$37.8M Sell
31,742
-487
-2% -$744K 0.02% 798
2019
Q2 		$53.1M Buy
+32,229
New +$55.8M 0.02% 654
2018
Q1 		– Sell
-265
Closed -$611K – 1075
2017
Q4 		$611K Sell
265
-2
-0.7% -$4.06K ﹤0.01% 865
2017
Q3 		$474K Hold
267
– – ﹤0.01% 918
2017
Q2 		$363K Sell
267
-910
-77% -$1.1M ﹤0.01% 991
2017
Q1 		$1.39M Sell
1,177
-781
-40% -$797K 0.01% 832
2016
Q4 		$1.56M Sell
1,958
-55
-3% -$43.7K 0.01% 973
2016
Q3 		$1.77M Buy
+2,013
New +$1.46M 0.01% 843
2015
Q4 		– Sell
-8,536
Closed -$9.46K – 1525
2015
Q3 		$9.46K Buy
8,536
+815
+11% +$1.49M 0.05% 342
2015
Q2 		$16.8K Sell
7,721
-1,363
-15% -$2.78M 0.09% 277
2015
Q1 		$14.2M Sell
9,084
-748
-8% -$987K 0.08% 327
2014
Q4 		$11.7M Buy
+9,832
New +$6.57M 0.07% 358

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.28B AUM 41.08% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $187M AUM 179.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Nuveen's BLUE Position: Q1 2025 in Review

Nuveen sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 12,721 shares — an estimated $106K sold.

Nuveen first reported a position in BLUE in Q4 2014 and held it in 33 quarters. The position peaked at $53.1M in Q2 2019. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • Nuveen reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
  • Nuveen sold 12,721 bluebird bio shares in Q1 2025, an estimated $106K.
  • Nuveen first reported a position in bluebird bio in Q4 2014 and held it in 33 quarters.
  • Nuveen's bluebird bio position peaked at $53.1M in Q2 2019.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Nuveen's 13F filing for Q1 2025, filed 12 May 2025.